课题基金 / 基金详情

Nuclear receptor regulation of a breast cancer stem cell population

Nuclear receptor regulation of a breast cancer stem cell population
乳腺癌干细胞群的核受体调节
批准号:
9516953
负责人:
Lynsey M Fettig Anderson
金额:
$3.44万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2019-06-16
关键词:
AffectAromatase InhibitorsAttenuatedBindingBiological AssayBreastBreast Cancer CellBreast Cancer PreventionBreast Cancer TreatmentBreast Cancer cell lineCell CountCell LineCellsCessation of lifeCharacteristicsConsensusCytokeratinDNA BindingDataDependenceDisease OutcomeDrug resistanceEndocrineEstrogen ReceptorsEstrogensExhibitsGene Expression RegulationGenesGenetic TranscriptionGoalsGrowthHormonalHormone replacement therapyHormonesHumanIn VitroLaboratoriesLuciferasesMalignant NeoplasmsMammospheresMediatingModelingMutateNewly DiagnosedNuclear ReceptorsPatientsPopulationPostmenopauseProgesteroneProgesterone ReceptorsProgestinsPromoter RegionsPropertyProteinsRecurrenceRegulationReporterResistanceResistance developmentResponse ElementsRetinoic Acid BindingRetinoic Acid ReceptorRetinoic Acid Response ElementRetinoidsRiskRoleSignal TransductionStem cellsStructural ProteinT47DTamoxifenTranscriptional RegulationTreatment EfficacyTretinoinTumor InitiatorsTumorigenicityUnited StatesWomanbreast cancer diagnosiscancer biomarkerscancer cellcancer diagnosiscancer recurrencecancer stem cellchemotherapychromatin immunoprecipitationcofactorgene inductiongene repressionhormone therapyimprovedimproved outcomein vitro Assayin vivoknock-downlifetime riskmalignant breast neoplasmmortalitynoveloverexpressionparacrinepreventprogesterone receptor positivepromoterprotein expressionreceptor bindingrecruitresponseretinoic acid receptor alpharetinoic acid receptor gammasmall hairpin RNAsmall moleculestem cell populationstem-like cellstemnesstheoriestherapy developmenttherapy resistanttumortumor initiationtumor xenografttumorigenic

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
Project Summary Breast cancer is the most commonly diagnosed cancer in women in the United States with a 1 in 8 lifetime risk for most women. It also ranks second highest in cancer related mortality. Nearly 75% of newly diagnosed breast cancer cases are estrogen receptor (ER) and often progesterone receptor (PR) positive and therefore treated using targeted endocrine therapies such as Tamoxifen (Tam) and Aromatase Inhibitors (AIs). Unfortunately 40% of patients with ER+ breast cancer will acquire resistance to these therapies and have a tumor recurrence. While the role of estrogen in breast cancer has been extensively studied, the role of PR has been largely overlooked. Activation of PR via progestins in hormone replacement therapy has been shown to be associated with an increased risk of developing breast cancer in post-menopausal women. It has been theorized that this may be due to expansion of the stem cell populations in the normal breast, which are expanded in response to progestins and are more susceptible to transformation. In the normal breast, these stem and progenitor cell populations expanded by progesterone are marked by expression of cytokeratin 5 (CK5). Similarly, the Sartorius laboratory found that in ER+/PR+ breast cancer cell lines, progesterone can expand the CK5 expressing cell population, which has been shown to mark a cancer stem cell (CSC) population in these ER+/PR+ cell lines. The lab also found that this CK5 expressing population is more tumorigenic both in vitro and in vivo, and more resistant to chemo- and endocrine therapies. A small molecule screen performed by the lab determined that select retinoids, including retinoic acid (RA), are able to prevent the induction of CK5 seen following P4 treatment of breast cancer cells. It is not known, however, how RA is able to prevent the induction of CK5 or whether the expression of CK5 is necessary to confer these cancer stem cell-like properties. The studies proposed here will unravel the mechanism by which hormones positively or negatively regulate a CSC population within ER+PR+ breast cancer, and have the potential to identify a means to target this CSC population with the ultimate goal of reducing recurrence and improving the outcome of this disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
海外基金